IP Library Assignment 034836/0690
Patent Assignment
Reel/Frame 034836/0690

Assignment of Assignor's Interest

Recorded: 2015-01-28 Pages: 19
Assignor
GENAERA LIQUIDATING TRUST
Executed: 2009-08-21
Assignee
OHR PHARMACEUTICAL, INC.
489 5TH AVENUE, 28TH FLOOR, NEW YORK, NEW YORK, 10017
Covered Property (1)
Polymorphic and Amorphous Salt Forms of Squalamine Dilactate
Patent: 8,716,270 →
Application: 13/166,911 →
Publication: US 2012/0022035
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 28, 2015
From: CHELLQUIST, ERIC; DOUBLEDAY, MARY; GILBERT, CHARLES; ZHANG, XUEHAI
To: GENAERA CORPORATION
Reel/Frame 034836/0672 →
Liquidating Trust Agreement Jan 28, 2015
From: GENAERA CORPORATION
To: ARGYCE LLC
Reel/Frame 034838/0844 →
Certificate of Change of the Company's Address Mar 22, 2016
From: OHR PHARMACEUTICAL, INC.
To: OHR PHARMACEUTICAL, INC.
Reel/Frame 038215/0748 →
Assignment of Assignor's Interest May 10, 2018
From: OHR PHARMACEUTICAL, INC.
To: ENTERIN, INC.
Reel/Frame 045764/0322 →